Donate
Families and researchers are counting on you !

Search

Do a search on the AFM-Telethon website.

(optional)
AFM-Telethon's organization : Laurent Tiennot-Herment, Chair of AFM-Telethon
Page
25/06/2024

Our organization 

Committed to scientific research as well as to the support of patients and their families, AFM-Telethon acts independently, guided only by the urgency of the progressive disease, for the benefit of patients.  

Pertinence1
Pertinence1
23/08/2022

Contact us

Phone number: + 33 1 69 47 28 28

Postal address:
Association Française contre les Myopathies,
1, rue de l’Internationale,
91002 Evry,
France

Pertinence1
Page
23/08/2022

Terms and conditions

You are now on a website that is edited by the French Muscular Dystrophy Association (AFM-Téléthon), a 1901 law association of public utility. Its headquarters are based in Paris : AFM-Institut de Myologie, 47-83 boulevard de l’Hôpital, 75651 Paris Cedex 13.

Pertinence1
Rubrique
23/08/2022

Our victories against the disease

From formerly unknown diseases to conquered diseases, a medical revolution is underway and victories are multiplying.

Pertinence1
Rubrique
23/08/2022

Resources

Find here information on diseases : advances of research booklets presenting the lastest information on a given disease or group of diseases, information on trials and access to the Myobase portal. 

Pertinence1
AFM-Telethon's fights for patients with a neuromuscular disease, rare disease and people with a disability
Page
23/08/2022

Our fights

AFM-Telethon has long struggled to defend the rights of patients, of people living with disabilities, and to obtain recognition for rare diseases. As a driver of research and innovation, it defends an ambitious national policy.  

Pertinence1
AFM-Telethon's strategy of general interest
Page
23/08/2022

A strategy of general interest

The AFM-Telethon has chosen to implement a strategy of public interest to benefit as many people as possible.  

Pertinence1
AFM-Telethon-bioproduction-revolution: The challenge of industrializing their production is a crucial one.
Page
23/08/2022

The bioproduction revolution 

While the first gene therapy drugs are obtaining marketing authorization and being made available to patients, the challenge of industrializing their production is a crucial one.

Pertinence1
La révolution de la myologie par l'AFM-Téléthon qui en fait une discipline à part entière
Page
23/08/2022

The myology revolution 

Peeling an apple. Lifting your arms. Walking. Smiling. Breathing. These routine actions use muscles and we accomplish them without thinking. But with neuromuscular diseases, the muscles are attacked and movement is prevented. In order to better treat them, AFM-Telethon wants to make myology a separate discipline. 

Pertinence1
AFM-Telethon-become-partner: your company can get involved in various ways.
Page
23/08/2022

Become a partner 

Participation in the Telethon or support for our therapeutic and social innovation projects, your company can get involved in various ways. Find out how to become a partner/sponsor of AFM-Telethon.

Pertinence1
Je veux participer au Téléthon
Page
23/08/2022

Join the Telethon for French people abroad

The French Telethon also takes place abroad. French expatriates can join in this 30-hour marathon of celebration and solidarity from all over the world. You live abroad and want to be part of the great Telethon adventure? Join us!  

Pertinence1
Make a legacy: You can pass on not only your genes.
Page
23/08/2022

Passing on your estate  

You can pass on not only your genes It is above all about deep convictions, to last beyond your lifetime.  

Pertinence1
AFM-TÉLÉTHON uses donations to develop new therapies
Page
23/08/2022

The biotherapy revolution 

Gene, cellular and pharmacogenetic therapy: AFM-Telethon uses donations to develop new therapies for the most frequent rare diseases.   

Pertinence1
AFM-Telethon's activities to strengthen the place of patients in Europe and worldwide
Page
23/08/2022

Our international activities

AFM-Telethon puts the power of patients at the core of its international activities, with the aim of strengthening the place of French neuromuscular patients in Europe and in the world. 

Pertinence1